Streetbeat News

Price Targets

TMHC

Taylor Morrison Home (NYSE:TMHC) received 4 analyst ratings in the last quarter, with 2 bullish and 2 indifferent, and no bearish ratings. The average price target is $49.25, representing a slight upside from the current price of $48.25. This target is a 4.05% decrease from the previous target of $51.33. Analyst ratings are opinions on stock performance based on research and are updated typically once a quarter.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 3:01 pm

SMAR

Over the last quarter, Smartsheet (NYSE:SMAR) received 6 analyst ratings: 3 bullish, 2 somewhat bullish, and 1 indifferent. The average price target is $53.17, suggesting an upside from the current price of $45.555. This target has decreased by 1.54% from the previous target of $54.00. Analysts use various data sources to provide ratings and forecasts, which can influence investor decisions but are subject to human error.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 3:00 pm

ALXO

ALX Oncology Holdings (NASDAQ:ALXO) has received positive analyst ratings in the last quarter, with 7 analysts offering a 12-month price target averaging $17.79, an 18.6% increase from the previous target of $15.00. The ratings include 4 bullish and 3 somewhat bullish, with a high target of $27.00 and a low of $10.00.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 3:00 pm

SHLS

Shoals Technologies Gr (NASDAQ:SHLS) has received various analyst ratings over the last quarter, with 6 bullish, 4 somewhat bullish, 3 indifferent, and no bearish ratings. The average 12-month price target among 13 analysts is $25.15, with a high of $33.00 and a low of $17.00. This target is a 12.28% decrease from the previous average target of $28.67. Analysts use various methods and metrics to determine their ratings and predictions for stocks.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 3:00 pm

SLAB

Analysts have provided ratings for Silicon Laboratories (NASDAQ:SLAB) with 1 bullish, 2 somewhat bullish, and 2 indifferent ratings in the last quarter. The average price target is $128.2, representing an upside from the current price of $117.67. This is an 18.6% decrease from the previous average price target of $157.50. Analysts typically review stocks once a quarter and provide forecasts on earnings, revenue, and growth, although their predictions are not infallible.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 3:00 pm

WIX

Wix.com (NASDAQ:WIX) received 7 analyst ratings in the last quarter, with 5 bullish and 2 somewhat bullish, and none indifferent, somewhat bearish, or bearish. The average 12-month price target for WIX is $125.14, with a high of $132.00 and a low of $103.00. This target has increased by 6.5% over the past month. Analysts typically rate stocks each quarter based on detailed research and provide guidance on growth estimates, earnings, and revenue.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 3:00 pm

CNM

Barclays analyst Matthew Bouley has maintained an Overweight rating on Core & Main (NYSE:CNM) and increased the price target from $38 to $49, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 2:58 pm

KURA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Kura Oncology (NASDAQ:KURA) and maintained a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 2:47 pm

RIGL

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Rigel Pharmaceuticals (NASDAQ:RIGL) and maintained a $15 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 2:44 pm

GNFT

HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating on Genfit (NASDAQ:GNFT) and maintained a price target of $11. This reaffirmation of the stock's potential could influence investor sentiment and stock performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 2:39 pm